(CRSP) Crispr Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Crispr Therapeutics | (CRSP) share price targets
Complete technical analysis of Crispr Therapeutics (CRSP) by charts plus indicators, forecast predictions and share price targets for Crispr Therapeutics (CRSP)
Crispr Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-07-31 View latest technical analysis
10 day averaged volume of Crispr Therapeutics is 1220117
Date | Daily Closing Price | Open | High | Low | Volume |
31 Wed Jul 2024 | 57.29 | 56.73 | 59.50 | 56.02 | 0.845 times |
30 Tue Jul 2024 | 56.41 | 57.92 | 58.04 | 55.83 | 1.055 times |
29 Mon Jul 2024 | 58.50 | 57.95 | 59.07 | 56.50 | 0.656 times |
26 Fri Jul 2024 | 57.92 | 58.49 | 59.77 | 57.35 | 0.711 times |
25 Thu Jul 2024 | 57.57 | 55.38 | 58.76 | 55.31 | 0.89 times |
24 Wed Jul 2024 | 55.39 | 56.19 | 57.20 | 55.26 | 0.862 times |
23 Tue Jul 2024 | 57.19 | 56.08 | 58.49 | 55.93 | 0.789 times |
22 Mon Jul 2024 | 56.24 | 55.20 | 56.39 | 54.06 | 0.991 times |
19 Fri Jul 2024 | 54.56 | 56.08 | 56.21 | 54.01 | 1.141 times |
18 Thu Jul 2024 | 56.21 | 60.84 | 61.47 | 55.82 | 1.604 times |
My analysis of stock is bullish for shortterm, and stock might move up till 58.9 or till 61.7. Use a stoploss of 56.68 and if this stock hits its stoploss, then it can fall down till 54.41
Share price targets for Crispr Therapeutics (CRSP)
Target Type | Value |
Downside Target | 51.02 |
Downside Target | 52.31 |
Upside Target | 59.18 |
Upside Target | 59.77 |
Upside Target | 60.20 |
Upside Target | 63.68 |
Upside Target | 67.52 |
Upside Target | 67.88 |
Upside Target | 68.39 |
Upside Target | 87.08 |
Intraday share price targets for Crispr Therapeutics (CRSP)
Target Type | Value |
Downside Intraday Target | 55.58 |
Downside Intraday Target | 53.87 |
Upside Intraday Target | 59.25 |
Upside Intraday Target | 61.21 |
Upside Intraday Target | 57.54 |
Weekly technical analysis of Crispr Therapeutics (CRSP)
Date | Weekly Closing Price | Open | High | Low | Volume |
31 Wed Jul 2024 | 57.29 | 57.95 | 59.50 | 55.83 | 0.602 times |
26 Fri Jul 2024 | 57.92 | 55.20 | 59.77 | 54.06 | 0.573 times |
19 Fri Jul 2024 | 54.56 | 57.95 | 63.68 | 54.01 | 1.45 times |
12 Fri Jul 2024 | 57.90 | 53.66 | 60.20 | 52.83 | 3.546 times |
05 Fri Jul 2024 | 53.10 | 53.60 | 54.74 | 52.31 | 0.58 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Crispr Therapeutics (CRSP)
Date | Monthly Closing Price | Open | High | Low | Volume |
31 Wed Jul 2024 | 57.29 | 54.02 | 63.68 | 52.31 | 0.995 times |
28 Fri Jun 2024 | 54.01 | 54.82 | 67.88 | 53.33 | 1.023 times |
31 Fri May 2024 | 53.74 | 53.16 | 59.18 | 51.02 | 0.974 times |
30 Tue Apr 2024 | 52.99 | 68.14 | 68.39 | 52.73 | 1.058 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Crispr Therapeutics (CRSP)
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Crispr Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Crispr Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Crispr Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 56.55 and Crispr Therapeutics (CRSP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Crispr Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Crispr Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Crispr Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 56.55 and Crispr Therapeutics (CRSP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.